Logo
x

Search

Subscribe Now

Roche

Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)

Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)

  • July 30, 2024
Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)

Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)

  • July 18, 2024
Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity

Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity

  • July 17, 2024
Roche’s Accu-Chek SmartGuide CGM System Gains CE Mark for Diabetic Patients

Roche’s Accu-Chek SmartGuide CGM System Gains CE Mark for Diabetic Patients

  • July 9, 2024
Roche’s Vabysmo Prefilled Syringe Receives the US FDA’s Approval for Vision Loss

Roche’s Vabysmo Prefilled Syringe Receives the US FDA’s Approval for Vision Loss

  • July 5, 2024
Roche Reports P-II/III (SKYSCRAPER-06) Trial Data of Tiragolumab to Treat Non-Squamous Non-Small Cell Lung Cancer

Roche Reports P-II/III (SKYSCRAPER-06) Trial Data of Tiragolumab to Treat Non-Squamous Non-Small Cell Lung Cancer

  • July 4, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.